<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002726.ref051">
 <label>51</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Collins</surname>
   <given-names>MH</given-names>
  </name>, 
  <name>
   <surname>McGowan</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Jadi</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Young</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Lopez</surname>
   <given-names>CA</given-names>
  </name>, 
  <name>
   <surname>Baric</surname>
   <given-names>RS</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection</article-title>. 
  <source>Emerg Infect Dis</source>. 
  <year>2017</year>;
  <volume>23</volume>(
  <issue>5</issue>):
  <fpage>773</fpage>â€“
  <lpage>81</lpage>. 
  <pub-id pub-id-type="doi">10.3201/eid2305.161630</pub-id>
  <?supplied-pmid 28418292?>
  <pub-id pub-id-type="pmid">28418292</pub-id>
 </mixed-citation>
</ref>
